Enhanced Circulating Half-Life and Antitumor Activity of a Site-Specific Pegylated Interferon-α Protein Therapeutic
Year: 2007
Type: article
Source: Bioconjugate Chemistry
DOI: 10.1021/bc070131q
Institutions: University of Colorado Boulder, Bolder Biotechnology, Inc.
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2024368730
